Interleukin 10 (IL-10) promoter polymorphism is associated with increased mortality in severe sepsis (16), susceptibility to chronic hepatitis C virus (HCV) infection, resistance to antiviral therapy (17), and predisposition to Epstein Barr virus (EBV) infection (18). This evidence concerns the gene IL10 and Sepsis.